The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 32.98%.However, over the last six months, we can see a weaker performance of 18.71%. Over the last 30 days, the price of RPRX has fallen by 2.18%. And in the last five days, it has fallen by -0.75%.
At present, Royalty Pharma plc (RPRX) has a stock price of $35.6. In the previous session, the stock saw a rise, peaking at $51.0 after an opening price of $35.6. The day’s lowest price was $32.19, and it closed at $36.51.
Royalty Pharma plc experienced a rather steady stock market performance. The highest value in the past year was recorded at $36.69 on 07/16/25 and the lowest value was $24.05 on 12/19/24.
52-week price history of RPRX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Royalty Pharma plc’s current trading price is -2.97% away from its 52-week high, while its distance from the 52-week low is 48.02%. The stock’s price range during this period has varied between$24.05 and $36.69. The Royalty Pharma plc’s shares, which operate in the Healthcare, saw a trading volume of around 3.75 million for the day, a figure considerably lower than their average daily volume of 4.79 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Royalty Pharma plc (RPRX) has experienced a quarterly rise of 10.25% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 20.02B and boasts a workforce of 99 employees.
Royalty Pharma plc: Analysts’ Ratings Unveiled
As of right now, 3 analysts are rating Royalty Pharma plc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 33.42, with a change in price of +2.27. Similarly, Royalty Pharma plc recorded 4,693,114 in trading volume during the last 100 days, posting a change of +6.81%.
RPRX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RPRX stands at 1.14. Similarly, the long-term debt-to-equity ratio is also 0.99.
RPRX Stock Stochastic Average
Royalty Pharma plc’s raw stochastic average for the past 50 days is presently 73.78%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 48.40%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 75.28% and 79.35%, respectively.
